B4GALNT3 and colorectal carcinoma: Recently, it was demonstrated that B4GALNT3 modifies the N-glycans of EGFR with LacdiNAc, and the knockdown of B4GALNT3 inhibits EGF-induced migration and invasion in CRC cell lines.